These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 27609061)

  • 1. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine.
    Good M; Sodhi CP; Yamaguchi Y; Jia H; Lu P; Fulton WB; Martin LY; Prindle T; Nino DF; Zhou Q; Ma C; Ozolek JA; Buck RH; Goehring KC; Hackam DJ
    Br J Nutr; 2016 Oct; 116(7):1175-1187. PubMed ID: 27609061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialylated galacto-oligosaccharides and 2'-fucosyllactose reduce necrotising enterocolitis in neonatal rats.
    Autran CA; Schoterman MH; Jantscher-Krenn E; Kamerling JP; Bode L
    Br J Nutr; 2016 Jul; 116(2):294-9. PubMed ID: 27212112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling.
    Yazji I; Sodhi CP; Lee EK; Good M; Egan CE; Afrazi A; Neal MD; Jia H; Lin J; Ma C; Branca MF; Prindle T; Richardson WM; Ozolek J; Billiar TR; Binion DG; Gladwin MT; Hackam DJ
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9451-6. PubMed ID: 23650378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human milk oligosaccharides 2'-fucosyllactose and 6'-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling.
    Sodhi CP; Wipf P; Yamaguchi Y; Fulton WB; Kovler M; Niño DF; Zhou Q; Banfield E; Werts AD; Ladd MR; Buck RH; Goehring KC; Prindle T; Wang S; Jia H; Lu P; Hackam DJ
    Pediatr Res; 2021 Jan; 89(1):91-101. PubMed ID: 32221473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human milk oligosaccharide 2'-fucosyllactose links feedings at 1 month to cognitive development at 24 months in infants of normal and overweight mothers.
    Berger PK; Plows JF; Jones RB; Alderete TL; Yonemitsu C; Poulsen M; Ryoo JH; Peterson BS; Bode L; Goran MI
    PLoS One; 2020; 15(2):e0228323. PubMed ID: 32049968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical safety evaluation of the synthetic human milk, nature-identical, oligosaccharide 2'-O-Fucosyllactose (2'FL).
    Coulet M; Phothirath P; Allais L; Schilter B
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):59-69. PubMed ID: 24262411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen Sulfide Donor GYY4137 Acts Through Endothelial Nitric Oxide to Protect Intestine in Murine Models of Necrotizing Enterocolitis and Intestinal Ischemia.
    Drucker NA; Jensen AR; Te Winkel JP; Markel TA
    J Surg Res; 2019 Feb; 234():294-302. PubMed ID: 30527488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Milk Oligosaccharide 2'-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model.
    Xiao L; Leusink-Muis T; Kettelarij N; van Ark I; Blijenberg B; Hesen NA; Stahl B; Overbeek SA; Garssen J; Folkerts G; Van't Land B
    Front Immunol; 2018; 9():452. PubMed ID: 29593719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Role for Necroptosis in the Pathogenesis of Necrotizing Enterocolitis.
    Werts AD; Fulton WB; Ladd MR; Saad-Eldin A; Chen YX; Kovler ML; Jia H; Banfield EC; Buck RH; Goehring K; Prindle T; Wang S; Zhou Q; Lu P; Yamaguchi Y; Sodhi CP; Hackam DJ
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):403-423. PubMed ID: 31756560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of
    Mao B; He Z; Chen Y; Stanton C; Ross RP; Zhao J; Chen W; Yang B
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal change of selected human milk oligosaccharides and association to infants' growth, an observatory, single center, longitudinal cohort study.
    Sprenger N; Lee LY; De Castro CA; Steenhout P; Thakkar SK
    PLoS One; 2017; 12(2):e0171814. PubMed ID: 28182762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats.
    Jantscher-Krenn E; Zherebtsov M; Nissan C; Goth K; Guner YS; Naidu N; Choudhury B; Grishin AV; Ford HR; Bode L
    Gut; 2012 Oct; 61(10):1417-25. PubMed ID: 22138535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of endothelial nitric oxide synthase exacerbates intestinal and lung injury in experimental necrotizing enterocolitis.
    Drucker NA; Jensen AR; Te Winkel JP; Ferkowicz MJ; Markel TA
    J Pediatr Surg; 2018 Jun; 53(6):1208-1214. PubMed ID: 29618412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oligosaccharides 6'-sialyllactose, 2'-fucosyllactose or galactooligosaccharides do not directly modulate human dendritic cell differentiation or maturation.
    Perdijk O; van Neerven RJJ; van den Brink E; Savelkoul HFJ; Brugman S
    PLoS One; 2018; 13(7):e0200356. PubMed ID: 29990329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil attenuates intestinal injury in necrotizing enterocolitis independently of endothelial nitric oxide synthase.
    Hunter CE; Hosfield BD; Mesfin FM; Pecoraro AR; Liu J; Shelley WC; Manohar K; Markel TA
    J Pediatr Surg; 2022 Dec; 57(12):967-973. PubMed ID: 35794042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hydrogen-sulfide derivative of mesalamine reduces the severity of intestinal and lung injury in necrotizing enterocolitis through endothelial nitric oxide synthase.
    Hosfield BD; Hunter CE; Li H; Drucker NA; Pecoraro AR; Manohar K; Shelley WC; Markel TA
    Am J Physiol Regul Integr Comp Physiol; 2022 Oct; 323(4):R422-R431. PubMed ID: 35912999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota.
    Elison E; Vigsnaes LK; Rindom Krogsgaard L; Rasmussen J; Sørensen N; McConnell B; Hennet T; Sommer MO; Bytzer P
    Br J Nutr; 2016 Oct; 116(8):1356-1368. PubMed ID: 27719686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.
    Iribarren C; Magnusson MK; Vigsnæs LK; Aziz I; Amundsen ID; Šuligoj T; Juge N; Patel P; Sapnara M; Johnsen L; Sørensen N; Sundin J; Törnblom H; Simrén M; Öhman L
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis.
    Masi AC; Embleton ND; Lamb CA; Young G; Granger CL; Najera J; Smith DP; Hoffman KL; Petrosino JF; Bode L; Berrington JE; Stewart CJ
    Gut; 2021 Dec; 70(12):2273-2282. PubMed ID: 33328245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infants Fed a Lower Calorie Formula With 2'FL Show Growth and 2'FL Uptake Like Breast-Fed Infants.
    Marriage BJ; Buck RH; Goehring KC; Oliver JS; Williams JA
    J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):649-58. PubMed ID: 26154029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.